AMRUTANJAN

Amrutanjan Health Care Share Price

₹787.35
+ 2.45 (0.31%)
14 September, 2024 01:50 BSE: 590006 NSE: AMRUTANJAN ISIN: INE098F01031

Start SIP in Amrutanjan Health Care

Start SIP

Amrutanjan Health Care Performance

Day Range

  • Low 775
  • High 791
₹ 787

52 Week Range

  • Low 564
  • High 863
₹ 787
  • Open Price789
  • Previous Close785
  • Volume21664

Amrutanjan Health Care Chart

  • Over 1 Month + 2.73%
  • Over 3 Month + 4.55%
  • Over 6 Month + 26.06%
  • Over 1 Year + 25.46%

Amrutanjan Health Care Key Statistics

P/E Ratio 53.5
PEG Ratio -37.7
Market Cap Cr
Price to Book Ratio 7.9
EPS 15.5
Dividend 0.9
Relative Strength Index 49.91
Money Flow Index 74.39
MACD Signal 11.83
Average True Range 25.92

Amrutanjan Health Care Investment Rating

  • Master Rating:
  • Amrutanjan Health Care has an operating revenue of Rs. 427.10 Cr. on a trailing 12-month basis. An annual revenue growth of 11% is good, Pre-tax margin of 15% is great, ROE of 15% is good. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading close to its 50DMA and comfortably placed above its 200DMA, around 17% above 200DMA. It needs to take support around the 50 DMA level to continue further upside move. It has recently broken out of a base in its weekly chart and is trading around -4% from the pivot point (which is the ideal buying range for a stock). From an O'Neil Methodology perspective, the stock has an EPS Rank of 38 which is a POOR score indicating inconsistency in earnings, a RS Rating of 47 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at B+ which is evident from recent demand for the stock, Group Rank of 55 indicates it belongs to a fair industry group of Medical-Generic Drugs and a Master Score of C is fair but needs to improve. Institutional holding has gone up in the last reported quarter is a positive sign. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.

EPS Strength

Price Strength

Buyer Demand

Group Rank

Amrutanjan Health Care Financials
IndicatorJun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023
Oper Rev Qtr Cr 841271179978100
Operating Expenses Qtr Cr 8011195927187
Operating Profit Qtr Cr 416227713
Depreciation Qtr Cr 222211
Interest Qtr Cr 000000
Tax Qtr Cr 266224
Net Profit Qtr Cr 514177713
IndicatorMar 2024Mar 2023
Total Revenue Annual Cr 438394
Operating Expenses Annual Cr 370335
Operating Profit Annual in Cr 5144
Depreciation Cr 65
Interest Annual Cr 00
Tax Annual Cr 1714
Net Profit Annual Cr 4540
IndicatorMar 2024Mar 2023
Cash from Operating Activity Annual Cr 2820
Cash from Investing Activity Annual Cr 19-2
Cash from Financing Annual Activity Cr -48-15
Net Cash Flow Annual Cr -13
IndicatorMar 2024Mar 2023
Total ShareHolders Funds Annual Cr 288291
Fixed Assets Annual Cr 5250
Total Non Current Assets Annual Cr 71103
Total Current Assets Annual Cr 296260
Total Assets Annual Cr 367362
IndicatorMar 2024Mar 2023
Book Value Per Share Annual Rs 10099
ROE Annual % 1614
ROCE Annual % 2118
Total Debt to Total Equity Annual --
EBDIT Annual Margin % 1616
IndicatorJun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023
Oper Rev Qtr Cr
Operating Expenses Qtr Cr
Operating Profit Qtr Cr
Depreciation Qtr Cr
Interest Qtr Cr
Tax Qtr Cr
Net Profit Qtr Cr
IndicatorMar 2024Mar 2023
Total Revenue Annual Cr
Operating Expenses Annual Cr
Operating Profit Annual in Cr
Depreciation Cr
Interest Annual Cr
Tax Annual Cr
Net Profit Annual Cr
IndicatorMar 2024Mar 2023
Cash from Operating Activity Annual Cr
Cash from Investing Activity Annual Cr
Cash from Financing Annual Activity Cr
Net Cash Flow Annual Cr
IndicatorMar 2024Mar 2023
Total ShareHolders Funds Annual Cr
Fixed Assets Annual Cr
Total Non Current Assets Annual Cr
Total Current Assets Annual Cr
Total Assets Annual Cr
IndicatorMar 2024Mar 2023
Book Value Per Share Annual Rs
ROE Annual %
ROCE Annual %
Total Debt to Total Equity Annual --
EBDIT Annual Margin %

Amrutanjan Health Care Technicals

EMA & SMA

Current Price
₹787.35
+ 2.45 (0.31%)
pointer
  • Bullish Moving Average
  • ___
  • 8
  • Bearish Moving Average
  • ___
  • 8
  • 20 Day
  • ₹792.02
  • 50 Day
  • ₹774.09
  • 100 Day
  • ₹747.12
  • 200 Day
  • ₹711.43
  • 20 Day
  • ₹796.56
  • 50 Day
  • ₹771.70
  • 100 Day
  • ₹752.55
  • 200 Day
  • ₹685.07

Amrutanjan Health Care Resistance and Support

PIVOT
₹784.42
Resistance
First Resistance 793.83
Second Resistance 800.32
Third Resistance 809.73
RSI 49.91
MFI 74.39
MACD Single Line 11.83
MACD 7.74
Support
First Support 777.93
Second Support 768.52
Third Supoort 762.03

Amrutanjan Health Care Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 24,502 1,237,106 50.49
Week 26,324 1,327,772 50.44
1 Month 131,962 5,401,211 40.93
6 Month 79,067 3,639,447 46.03

Amrutanjan Health Care Result Highlights

Amrutanjan Health Care Synopsis

NSE-Medical-Generic Drugs

Amrutanjan Health Ca is involved in the business activities of Manufacture of `ayurvedic’ or `unani’ pharmaceutical preparation. Company’s Total Operating Revenue is Rs. 421.23 Cr. and Equity Capital is Rs. 2.89 Cr. for the Year ended 31/03/2024. Amrutanjan Health Care Ltd. is a Public Limited Listed company incorporated on 09/09/1936 and has its registered office in the State of Tamil Nadu, India. Company’s Corporate Identification Number(CIN) is L24231TN1936PLC000017 and registration number is 000017.
Market Cap 2,269
Sales 427
Shares in Float 1.42
No of funds 31
Yield 0.59
Book Value 7.87
U/D Vol ratio 1.5
LTDebt / Equity
Alpha 0.04
Beta 0.65

Amrutanjan Health Care Shareholding Pattern

Owner NameJun-24Mar-24Dec-23Sep-23
Promoters 50.59%50.59%50.59%50.59%
Mutual Funds 6.76%6.79%6.79%6.79%
Foreign Portfolio Investors 1.55%1.38%0.8%0.75%
Financial Institutions/ Banks 0.09%0.09%0.09%0.09%
Individual Investors 33.87%34.16%34.61%34.99%
Others 7.14%6.99%7.12%6.79%

Amrutanjan Health Care Management

Name Designation
Mr. S Sambhu Prasad Chairman & Managing Director
Dr. Pasumarthi S N Murthi Non Executive Director
Mr. G Raghavan Ind. Non-Executive Director
Ms. Ramaa Prabhakar Arikirevula Non Executive Director
Ms. Meenalochani Raghunathan Ind. Non-Executive Director
Mr. Raja Venkataraman Ind. Non-Executive Director
Mr. S Muralidharan Ind. Non-Executive Director

Amrutanjan Health Care Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Amrutanjan Health Care Corporate Action

Date Purpose Remarks
2024-08-13 Quarterly Results
2024-05-23 Audited Results & Final Dividend
2024-02-09 Quarterly Results & Interim Dividend
2023-11-10 Quarterly Results & Interim Dividend
2023-08-02 Quarterly Results
Date Purpose Remarks
2024-02-20 INTERIM Rs.1.00 per share(100%)Second Interim Dividend
2023-11-23 INTERIM Rs.1.00 per share(100%)Interim Dividend
2023-09-14 FINAL Rs.2.60 per share(260%)Final Dividend
2023-02-24 INTERIM Rs.1.00 per share (100%) Second Interim Dividend
2022-11-15 INTERIM Rs.1.00 per share(100%)First Interim Dividend

Amrutanjan Health Care FAQs

What is Share Price of Amrutanjan Health Care ?

Amrutanjan Health Care share price is ₹787 As on 14 September, 2024 | 01:36

What is the Market Cap of Amrutanjan Health Care ?

The Market Cap of Amrutanjan Health Care is ₹2276.3 Cr As on 14 September, 2024 | 01:36

What is the P/E ratio of Amrutanjan Health Care ?

The P/E ratio of Amrutanjan Health Care is 53.5 As on 14 September, 2024 | 01:36

What is the PB ratio of Amrutanjan Health Care ?

The PB ratio of Amrutanjan Health Care is 7.9 As on 14 September, 2024 | 01:36

Q2FY23
Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91
 
footer_form